door admin | apr 3, 2026 | news
Special webinar on the SERENITY Study We are excited to invite you to a special webinar on the SERENITY Study and its potential to change clinical practice in cardio-oncology. We would like you to join us on 9 April at 14.00 GMT (15.00 CET) for this Webinar. In this...
door admin | feb 5, 2026 | news
*Seminar Alert!* Registration is now open for our February Seminar! Topic: “SERENITY: developing an evidence-based decision support tool to support shared decisions about continuing or discontinuing antithrombotic medication for people with cancer towards the...
door admin | jan 12, 2026 | news
We are developing a decision support tool We are developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Results of a European Delphi...
door admin | dec 12, 2025 | news
Serenity joins the Quality of Life and Patient-Centred Care (QoL-PCC) cluster The cluster represents a key opportunity to advance oncology care. One of the main goals is to develop a unified vision around these concepts while establishing core axes related to Patient...
door admin | okt 12, 2025 | news
WP4: Delphi Process Through this Delphi study, the following aspects will be defined: characterisation of candidate patients for discussion about ATT deprescribing healthcare team roles in ATT decision-making specific information and communication requirements for...
